ASCO Annual Meeting

Healio.com brings you the highlights from the ASCO Annual Meeting. Refer back to this page often to read the latest news from ASCO, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Meeting NewsVideo

VIDEO: Pembrolizumab represents ‘important option’ for metastatic urothelial cancer

June 25, 2017
CHICAGO — Improvements in response duration and side effect profile seen in the KEYNOTE-045 trial of pembrolizumab establish this therapy…
Meeting NewsVideo

VIDEO: Questions remain regarding use of gene-targeted therapy for lung cancer

June 23, 2017
CHICAGO — Suresh S. Ramalingam, MD, deputy director of Winship Cancer Institute of Emory University, discusses the results of a phase 3 trial…
Meeting NewsVideo

VIDEO: Adam Brufsky, MD, PhD, discusses results of MONARCH-2, PALOMA-1 trials

June 23, 2017
Adam M. Brufsky, MD, PhD, professor of medicine and co-director of the Comprehensive Breast Cancer Center at the University of Pittsburgh, discusses…
Meeting NewsVideo

VIDEO: High-intensity genomic assay may help ‘unlock mysteries’ in lung cancer treatment

June 23, 2017
CHICAGO — Edward S. Kim, MD, chair of solid tumor oncology and investigational therapeutics at the Levine Cancer Institute, and a HemOnc
Meeting NewsVideo

VIDEO: Updated KEYNOTE-024 results raise question in sequencing of lung cancer treatments

June 22, 2017
CHICAGO — Hossein Borghaei, DO, chief of the division of thoracic medical oncology at Fox Chase Cancer Center, discusses the updated…
Meeting NewsVideo

VIDEO: Entospletinib shows promise for advanced lymphoma

June 22, 2017
CHICAGO — Entospletinib appeared safe for patients with relapsed or refractory lymphoplasmacytoid lymphoma, according to study results…
Meeting News

Guest Commentary: STAMPEDE trial provides exciting results, questions in prostate cancer treatment

June 21, 2017
In this guest commentary, Terence Friedlander, MD, discusses the benefits associated with the addition of
Meeting News

Combination demonstrates activity in endometrial cancer

June 21, 2017
CHICAGO — The combination of lenvatinib and pembrolizumab conferred benefit to previously treated patients with metastatic endometrial cancer…
Meeting NewsVideo

VIDEO: Results of LATITUDE trial reinforce long-hypothesized theory in prostate cancer treatment

June 21, 2017
CHICAGO — The results of the LATITUDE trial demonstrated that the addition of abiraterone acetate with prednisone to standard hormonal therapy…
Meeting NewsVideo

VIDEO: Immunotherapy agent induces response in prostate cancer

June 20, 2017
CHICAGO — The use of sipuleucel-T in patients with hormone-sensitive and castration-resistant prostate cancer demonstrated an increase in the…
Advertisement
Advertisement